Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

Ann Intern Med. 2016 Apr 19;164(8):542-52. doi: 10.7326/M15-3016. Epub 2016 Mar 1.


Description: The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers, payers, and other interested parties with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.

Methods: The ADA Professional Practice Committee performed a systematic search on MEDLINE to revise or clarify recommendations based on new evidence. The committee assigns the recommendations a rating of A, B, or C, depending on the quality of evidence. The E rating for expert opinion is assigned to recommendations based on expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community was incorporated into the 2016 revision.

Recommendations: The synopsis focuses on 8 key areas that are important to primary care providers. The recommendations highlight individualized care to manage the disease, prevent or delay complications, and improve outcomes.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Blood Glucose Self-Monitoring
  • Cardiovascular Diseases / prevention & control
  • Diabetes Complications / prevention & control*
  • Diabetes Mellitus / diagnosis*
  • Diabetes Mellitus / therapy*
  • Diabetes Mellitus, Type 1 / therapy
  • Diabetes Mellitus, Type 2 / therapy
  • Diabetic Angiopathies / prevention & control
  • Diabetic Nephropathies / prevention & control
  • Diabetic Neuropathies / prevention & control
  • Glycated Hemoglobin / metabolism
  • Hospitalization
  • Humans
  • Hyperglycemia / therapy
  • Hypoglycemia / therapy
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Prediabetic State / diagnosis
  • Risk Factors


  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin